These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9769526)

  • 1. Chronic hepatitis C infection. A disease ideally suited to management in the primary care setting.
    Dore GJ
    Aust Fam Physician; 1998 Sep; 27(9):791-3. PubMed ID: 9769526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of obesity to hepatitis C-related fibrosis progression.
    Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J
    Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of patients with hepatitis C virus infection. Virological tests].
    Pawlotsky JM
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B180-7. PubMed ID: 12180286
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic approach to chronic hepatitis B and C in the dawn of the third millenium].
    Adler M; Bourgeois N
    Rev Med Brux; 2001 Jun; 22(3):141-51. PubMed ID: 11488081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of initially mild chronic hepatitis C.
    Alberti A; Benvegnù L; Boccato S; Ferrari A; Sebastiani G
    Dig Liver Dis; 2004 Oct; 36(10):646-54. PubMed ID: 15506661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy concepts in chronic hepatitis C].
    Meyer-Wyss B
    Schweiz Med Wochenschr; 1998 Dec; 128(49):1940-5. PubMed ID: 9887472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases.
    Georgiadou SP; Zachou K; Rigopoulou E; Liaskos C; Mina P; Gerovasilis F; Makri E; Dalekos GN
    J Viral Hepat; 2004 Jul; 11(4):358-65. PubMed ID: 15230859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of chronic hepatitis C.
    Pagliaro L; Peri V; Linea C; Cammà C; Giunta M; Magrin S
    Ital J Gastroenterol Hepatol; 1999; 31(1):28-44. PubMed ID: 10091101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
    Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
    Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C. Issues for women and their partners.
    Mazza D
    Aust Fam Physician; 1998 Sep; 27(9):795-8. PubMed ID: 9769527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.
    Collier JD; Woodall T; Wight DG; Shore S; Gimson AE; Alexander GJ
    J Viral Hepat; 2005 Jan; 12(1):74-80. PubMed ID: 15655051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.
    Okanoue T; Makiyama A; Nakayama M; Sumida Y; Mitsuyoshi H; Nakajima T; Yasui K; Minami M; Itoh Y
    J Hepatol; 2005 Oct; 43(4):599-605. PubMed ID: 16024129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels.
    Hui CK; Zhang HY; Shek T; Yao H; Yueng YH; Leung KW; Lai ST; Lai JY; Leung N; Lau GK
    Aliment Pharmacol Ther; 2007 Jun; 25(11):1283-92. PubMed ID: 17509096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of acute symptomatic hepatitis type C.
    Wawrzynowicz-Syczewska M; Kubicka J; Lewandowski Z; Boroń-Kaczmarska A; Radkowski M
    Infection; 2004 Jun; 32(3):138-43. PubMed ID: 15188072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistently normal alanine transaminase levels in chronic C hepatitis: what does it tell us?
    Dinçer D; Okten A; Kaymakoglu S; Besisik F; Demir K; Tuncer I; Bozaci M; Turkoglu S; Cevikbas U; Cakaloglu Y
    Hepatogastroenterology; 2001; 48(41):1397-400. PubMed ID: 11677973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis C: epidemiology and therapy--with special reference to long-term prognosis after IFN therapy].
    Fujiyama S; Tanaka M
    Rinsho Byori; 2000 Jan; 48(1):5-13. PubMed ID: 10756668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.